The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Assessing the pharmaceutical care issues of antiepileptic drug therapy in hospitalised epileptic patients
Abstract
Background Studies concerning epilepsy in the context of pharmaceutical care in Malaysia are lacking. Optimal pharmacotherapy management is necessary to achieve good seizure control. Aim To determine the pharmaceutical care issues in hospitalised epileptic patients. The factors associated with uncontrolled seizure and hospitalisation and the drug-related problems encountered are also described. Methods A cross-sectional study was conducted on 65 hospitalised epileptic patients until discharge. Prediction of dose adequacy and adherence, assessment of drug-related problems, adherence and outcome measurement of seizure control were analysed. Results Overall, 56.9% of patients defaulted from antiepileptic drug doses prior to seizure attack. The remaining 43.1% were affected by emotional stress, fever, weather and alcohol. The drug-related problems identified were non-adherence to medication (64.6%), dose inadequacy (51.9%), under-reporting of adverse effects (76.2%), under-utilisation of therapeutic drug monitoring services (41.5%) and inappropriateness of therapy in patients with liver disease. Nevertheless, medication adherence was found to be the major factor for uncontrolled epilepsy (odds ratio = 7.06, confidence interval = 1.29–38.56, p = 0.019). Among the non-adherers, only 19% received medication counselling upon discharge (p = 0.043). Conclusion Pharmacists need to address the drug-related problems in order to optimise drug therapy and achieve the desired treatment goal.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Berg, A. T., Berkovic, S. F., Brodie, M. J., Buchhalter, J., Cross, J. H., Van Emde Boas, W., Engel, J., French, J., Glauser, T. A., Mathern, G. W., et al. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02522.x · Cited by 4,363
The descriptive epidemiology of epilepsy—A review
Banerjee, P. N., Filippi, D., & Allen Hauser, W. (2009) · Epilepsy Research · doi:10.1016/j.eplepsyres.2009.03.003 · Cited by 929
Comparison of drug adherence rates among patients with seven different medical conditions
Briesacher, B. A., Andrade, S. E., Fouayzi, H., & Chan, K. A. (2008) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.28.4.437 · Cited by 587
Hovinga, C. A., Asato, M. R., Manjunath, R., Wheless, J. W., Phelps, S. J., Sheth, R. D., Pina-Garza, J. E., Zingaro, W. M., & Haskins, L. S. (2008) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2008.03.009 · Cited by 253
Drug treatment of epilepsy: Options and limitations
Schmidt, D. (2009) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2009.02.030 · Cited by 177
Managing patient adherence and quality of life in epilepsy
Eatock, J., & Baker, G. A. (2007) · Neuropsychiatric Disease and Treatment · doi:10.2147/nedt.2007.3.1.117 · Cited by 159
Prevalence and cost of nonadherence to antiepileptic drugs in elderly patients with epilepsy
Ettinger, A. B., Manjunath, R., Candrilli, S. D., & Davis, K. L. (2008) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2008.10.021 · Cited by 146
Antiepileptic drugs and liver disease
Ahmed, S. N., & Siddiqi, Z. A. (2006) · Seizure · doi:10.1016/j.seizure.2005.12.009 · Cited by 139
Adverse events with use of antiepileptic drugs: a prescription and event symmetry analysis
Tsiropoulos, I., Andersen, M. T., & Hallas, J. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1736 · Cited by 138
Sjölander, M., Eriksson, M., & Glader, E. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-003551 · Cited by 137
Cited by
Al-Worafi, Y. M. (2020) · Drug Safety in Developing Countries · doi:10.1016/b978-0-12-819837-7.00005-4 · Cited by 390
Self-citationMedications safety research issues
Al-Worafi, Y. M. (2020) · Drug Safety in Developing Countries · doi:10.1016/b978-0-12-819837-7.00019-4 · Cited by 383
Self-citationBaig, M. R., Al-Worafi, Y. M., Alseragi, W. M., Ming, L. C., & Siddique, A. (2020) · Drug Safety in Developing Countries · doi:10.1016/b978-0-12-819837-7.00025-x · Cited by 367
Self-citation
Metadata
- Authors
- Manan, M. M., Rusli, R. A., Ang, W. C., Al-Worafi, Y. M. A., & Ming, L. C.
- Venue
- Journal of Pharmacy Practice and Research
- Publisher
- Wiley
- Published
- 2014-09
- Volume
- 44
- Issue
- 3
- Pages
- 83-88
- ISSN
- 0310-6810 (ISSN-L)
- 1445-937X
- OpenAlex
- W1546032226
- Cited by
- 320
- References
- 17
- FWCI
- 1.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.